Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs. Intravenous TXA in TJA
NCT02233101Completed
- Sponsor
- Rush University Medical Center
- Start
- Jun 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of tranexamic acid (2 arms), sponsored by Rush University Medical Center. Primary endpoint: Number of Participants Who Required Blood Transfusion at 24 hours. Started Jun 2014; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT02233101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233101.